CVM (STOCKS)
Cel-Sci Corporation
$5.015000
+0.005000 (+0.10%)
Prev close: $5.010000
Company Information
- Exchange
- XASE
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Geert R. Kersten
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $41.71M
- Employees
- 44
- P/E (TTM)
- -0.63
- P/B (TTM)
- 2.44
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | -$648.94K |
| Benefits Costs and Expenses | -$26.06M |
| Costs And Expenses | -$26.06M |
| Operating Expenses | $24.81M |
| Depreciation and Amortization | $3.89M |
| Research and Development | $15.89M |
| Other Operating Expenses | $5.04M |
| Operating Income/Loss | -$24.81M |
| Income/Loss From Continuing Operations After Tax | $25.41M |
| Income/Loss From Continuing Operations Before Tax | $25.41M |
| Interest And Dividend Income, Operating | $56.00 |
| Interest Expense, Operating | $649.00K |
| Interest Income/Expense After Provision For Losses | -$648.94K |
| Interest Income/Expense Operating, Net | -$648.94K |
| Net Income/Loss | $25.41M |
| Net Income/Loss Attributable To Noncontrolling Interest | $50.82M |
| Net Income/Loss Attributable To Parent | -$25.41M |
| Net Income/Loss Available To Common Stockholders, Basic | -$25.41M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Diluted Earnings Per Share | -$6.27 |
| Diluted Average Shares | 4,055,738 |
| Assets | $28.16M |
| Current Assets | $11.60M |
| Prepaid Expenses | $332.30K |
| Other Current Assets | $11.26M |
| Noncurrent Assets | $16.56M |
| Fixed Assets | $6.08M |
| Other Non-current Assets | $10.48M |
| Liabilities | $12.20M |
| Current Liabilities | $5.13M |
| Accounts Payable | $1.06M |
| Other Current Liabilities | $4.07M |
| Noncurrent Liabilities | $7.07M |
| Equity | $15.96M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $15.96M |
| Liabilities And Equity | $28.16M |
| Net Cash Flow From Operating Activities | -$17.12M |
| Net Cash Flow From Operating Activities, Continuing | -$17.12M |
| Net Cash Flow From Investing Activities | -$38.11K |
| Net Cash Flow From Investing Activities, Continuing | -$38.11K |
| Net Cash Flow From Financing Activities | $23.37M |
| Net Cash Flow From Financing Activities, Continuing | $23.37M |
| Net Cash Flow | $6.22M |
| Net Cash Flow, Continuing | $6.22M |
| Comprehensive Income/Loss | $25.41M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $25.41M |
| Other Comprehensive Income/Loss | $0.00 |